BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30771950)

  • 1. Mass spectrometry based proteomic approach for the screening of butyrylcholinesterase adduct formation with organophosphates.
    Dubrovskii Y; Murashko E; Chuprina O; Beltyukov P; Radilov A; Solovyev N; Babakov V
    Talanta; 2019 May; 197():374-382. PubMed ID: 30771950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of soman and VX adducts to butyrylcholinesterase, their aged methylphosphonic acid adduct and butyrylcholinesterase in plasma using an off-column procainamide-gel separation method combined with UHPLC-MS/MS.
    Liu CC; Huang GL; Xi HL; Liu SL; Liu JQ; Yu HL; Zhou SK; Liang LH; Yuan L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():57-65. PubMed ID: 27718463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of phosphorylated butyrylcholinesterase in human plasma using immunoaffinity purification and mass spectrometry.
    Aryal UK; Lin CT; Kim JS; Heibeck TH; Wang J; Qian WJ; Lin Y
    Anal Chim Acta; 2012 Apr; 723():68-75. PubMed ID: 22444575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase.
    Jiang W; Murashko EA; Dubrovskii YA; Podolskaya EP; Babakov VN; Mikler J; Nachon F; Masson P; Schopfer LM; Lockridge O
    Anal Biochem; 2013 Aug; 439(2):132-41. PubMed ID: 23624322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Efficiency of Purification (from Human Plasma) of a Nerve Agent Adduct of Butyrylcholinesterase Between the Affinity Gel Method and Immunomagnetic Separation.
    Lee JY
    J Chromatogr Sci; 2018 Mar; 56(3):248-253. PubMed ID: 29244127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic detection of organophosphorus nerve agent adducts to butyrylcholinesterase in plasma using liquid chromatography-tandem mass spectrometry combined with an improved procainamide-gel separation and pepsin digestion method.
    Liu CC; Liang LH; Yan L; Chen B; Liu XJ; Yang Y; Liu SL; Xi HL
    J Chromatogr A; 2023 May; 1697():463990. PubMed ID: 37075496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
    Lee JY; Kim C; Lee YH
    J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbofuran poisoning detected by mass spectrometry of butyrylcholinesterase adduct in human serum.
    Li H; Ricordel I; Tong L; Schopfer LM; Baud F; Mégarbane B; Maury E; Masson P; Lockridge O
    J Appl Toxicol; 2009 Mar; 29(2):149-55. PubMed ID: 18937214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a LC/MS/MS method to analyze butyrylcholinesterase inhibition resulting from multiple pesticide exposure.
    Sun J; Lynn BC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3681-5. PubMed ID: 19783488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-throughput UHPLC-MS/MS method for the quantification of five aged butyrylcholinesterase biomarkers from human exposure to organophosphorus nerve agents.
    Graham LA; Johnson D; Carter MD; Stout EG; Erol HA; Isenberg SL; Mathews TP; Thomas JD; Johnson RC
    Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27572107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous detection of dual biomarkers from humans exposed to organophosphorus pesticides by combination of immunochromatographic test strip and ellman assay.
    Yang M; Zhao Y; Wang L; Paulsen M; Simpson CD; Liu F; Du D; Lin Y
    Biosens Bioelectron; 2018 May; 104():39-44. PubMed ID: 29306031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verification of exposure to cholinesterase inhibitors: generic detection of OPCW Schedule 1 nerve agent adducts to human butyrylcholinesterase.
    van der Schans MJ; Fidder A; van Oeveren D; Hulst AG; Noort D
    J Anal Toxicol; 2008; 32(1):125-30. PubMed ID: 18269804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.
    Tsuge K; Seto Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):21-30. PubMed ID: 16569519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct quantitation of methyl phosphonate adducts to human serum butyrylcholinesterase by immunomagnetic-UHPLC-MS/MS.
    Carter MD; Crow BS; Pantazides BG; Watson CM; Thomas JD; Blake TA; Johnson RC
    Anal Chem; 2013 Nov; 85(22):11106-11. PubMed ID: 24205842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of exposure to organophosphates: Generic mass spectrometric method for detection of human butyrylcholinesterase adducts.
    Noort D; Fidder A; van der Schans MJ; Hulst AG
    Anal Chem; 2006 Sep; 78(18):6640-4. PubMed ID: 16970345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective screening method for carbamate toxicant exposure based on butyrylcholinesterase adducts in human plasma with ultra-high performance liquid chromatography-tandem mass spectrometry.
    Ren Z; Chen B; Liang D; Liu D; Lei W; Liu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123775. PubMed ID: 37285767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of cresyl phosphate-modified butyrylcholinesterase in human plasma for chemical exposure associated with aerotoxic syndrome.
    Schopfer LM; Masson P; Lamourette P; Simon S; Lockridge O
    Anal Biochem; 2014 Sep; 461():17-26. PubMed ID: 24892986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers.
    Doorn JA; Schall M; Gage DA; Talley TT; Thompson CM; Richardson RJ
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):73-80. PubMed ID: 11601883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS.
    Johnson D; Carter MD; Crow BS; Isenberg SL; Graham LA; Erol HA; Watson CM; Pantazides BG; van der Schans MJ; Langenberg JP; Noort D; Blake TA; Thomas JD; Johnson RC
    J Mass Spectrom; 2015 Apr; 50(4):683-92. PubMed ID: 26149113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of immunosorbents coupled on-line to immobilized pepsin reactor and micro liquid chromatography-tandem mass spectrometry for analysis of butyrylcholinesterase in human plasma.
    Bonichon M; Combès A; Desoubries C; Bossée A; Pichon V
    J Chromatogr A; 2017 Dec; 1526():70-81. PubMed ID: 29055525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.